Should We Monitor Glucose and Biomarkers in Diabetics over Heart Surgery?

Hyperglycemia is associated with adverse outcomes after coronary artery bypass grafting (CABG). While there is a consensus that blood glucose control may benefit patients undergoing CABG, the role of biomarkers, optimal method, and duration of such monitoring are still unclear. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Golukhova, Elena Z., Lifanova, Ljubov S., Pugovkina, Yaroslava V., Grigoryan, Marina V., Bulaeva, Naida I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348301/
https://www.ncbi.nlm.nih.gov/pubmed/34362176
http://dx.doi.org/10.3390/jcm10153399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348301/
https://www.ncbi.nlm.nih.gov/pubmed/34362176
http://dx.doi.org/10.3390/jcm10153399

Ejemplares similares